All News

A Miami pharmacist recently pled guilty to charges she stole the identifying information of Medicare beneficiaries and then submitted fraudulent claims on their behalf.

Walmart is blaming lower margins in its pharmacy business for holding down overall corporate profits.

By joining together with other hospitals on medication purchasing and other efforts, Kalispell Regional Medical Center in Kalispell, Mt., has saved millions of dollars annually.

CVS Health recently introduced a new pharmacy service, ScriptSync, designed to enable patients with multiple Rxs to pick them up during one visit to the pharmacy.

Walgreens has agreed to pay $502,200 to settle charges that some of its pharmacists in California failed to provide patient consultations required by law.

Pharmacists open up about the ones that haunt their dreams.

Drug shortages are forcing hospitals to turn to compounded meds. It's time to develop a nationally recognized certification program for the practice of sterile compounding.

Patients with poorly controlled type 2 diabetes (T2DM) experienced a significant decline in their HbA1c levels when adding Technosphere inhaled insulin (Afrezza, MannKind Corp.) to their current treatment regimen, according to a new study.

U.S. District Court Judge Mark Kearney recently dismissed the class-action lawsuit of a Pennsylvania pharmacist who claimed CVS failed to pay him overtime pay.

Richmond University Medical Center, Staten Island, N.Y., recently opened the first fully-functioning retail pharmacy in a hospital in the area.

CVS/Caremark and Express Scripts, the two biggest players in the pharmacy benefits management industry, have both added medications to their exclusion lists.

Independent community pharmacists found plenty to think about at the recent McKesson ideaShare Conference in San Diego.

Natpara is indicated only as adjunctive therapy to calcium and vitamin D supplementation and is available only through a restricted REMS program.

Three community pharmacy professionals share their top tips on what makes pharmacists successful managers.

Interchangeability means different things to different stakeholders. Here are some things they will need to agree on.

Canada, the E.U., South Korea, Japan, India, and Australia - all have had clear regulatory pathways in place for years. The United States has been working on a biosimilars pathway for almost a decade. What's different?

The biosimilars pipeline is flush with new products, and it could be shortening. Here's why.

The picture looks somewhat better than it did a year ago, but many challenges remain.

Today’s pharmacist is much more than a healthcare professional who oversees the distribution of drugs. Pharmacists can be and often are the patient’s first-line healthcare educator and risk manager.

Note to pharmacies: Don't throw unshredded patient heath information into Dumpsters. Just don't.

New studies say yes.

Three successful pharmacy owners tell us how it's done.

The product-tracing deadline has been extended to November 1. Other requirements are on schedule. Here's what you have to do, and when you have to do it.

What does birth control have to do with medication adherence? David Stanley connects the dots.

Confronted by overwhelming workplace challenges, pharmacists sometimes forget they have options. It's time to step outside the limits of habitual thinking and take a look around.

Sterile compounders have voluntarily undertaken several upgrades to their processes and products. The results benefit patients, pharmacists, and the profession overall.

R&D and product manufacture are only the beginning. When the time comes to enter the marketplace, biosimilars still face numerous obstacles.

Some tips on making community connections